White House Seeks Increased Access to Overdose-Reversal Drug

Officials will talk with manufacturers to reduce the cost of naloxone.

A spokesperson for the White House Office of National Drug Control Policy (ONDCP) recently said that President Biden’s administration is interested in meeting with makers of naloxone to explore how best to make the life-saving opioid overdose reversal drug more readily available.

The Food and Drug Administration (FDA) approved Emergent BioSolutions’ naloxone drug Narcan for over-the-counter use earlier this year, and the president’s administration would like to find ways to maintain supplies of the drug while reducing costs for Americans.

According to the White House, ONDCP Director Rahul Gupta “plans to have conversations with manufacturers to share his key principle moving forward: the easier it is for people to access naloxone, the more lives we can save.”

As the Lord Leads, Pray with Us…

  • For the president and his health advisors as they consider the stockpiling of Narcan.
  • For Secretary Becerra to seek God’s guidance as he leads the Department of Health and Human Services.
  • For Director Gupta to look to the Lord for wisdom as he heads the White House Office of National Drug Control Policy.

Sources: Reuters, Department of Health and Human Services


Back to top